Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1).
Norman BH, Gruber JM, Hollinshead SP, Wilson JW, Starling JJ, Law KL, Self TD, Tabas LB, Williams DC, Paul DC, Wagner MM, Dantzig AH.
Norman BH, et al. Among authors: tabas lb.
Bioorg Med Chem Lett. 2002 Mar 25;12(6):883-6. doi: 10.1016/s0960-894x(02)00051-3.
Bioorg Med Chem Lett. 2002.
PMID: 11958985